Articles about Express

• Express Scripts added CARDAMYST (etripamil) nasal spray to its commercial national formularies effective March 27, 2026, expanding access for commercially insured patients. • The FDA-approved self-administered spray converts acute paroxysmal supraventricular tachycardia (PSVT) episodes to sinus rhythm in adults. • This coverage decision makes the first-in-class treatment broadly affordable across the U.S., improving cardiovascular care options.

Carlson in video claims the CIA is preparing a ‘crime report’ against him and alleges US agencies have read his textsTucker Carlson, the conservative US political commentator, has publicly expressed fear that he may be facing criminal charges for “acting as an agent of a foreign power” by communicating with people in Iran.The former CNN and Fox News host, who has established an alternative media career as online talking head and interviewer, claimed in a video posted on X that the Central Intelligence Agency (CIA) was preparing “a crime report” for the Trump administration’s justice department. Continue reading...

American Express stock pulled back to levels offering strong upside potential on March 13, 2026, prompting portfolio managers to track for additional purchases. The credit card giant benefits from premium products like the refreshed Platinum card driving earnings growth amid consumer spending resilience. Shares present a favorable entry as broader financials face pressure from rising yields and oil shocks. Analysts maintain a buy rating targeting significant appreciation from current levels around recent lows.

American Express stock has pulled back to attractive levels around recent lows on March 13, 2026, prompting portfolio managers to monitor for additional purchases with a revisit to buy rating. The company's premium Platinum card refresh is expected to drive higher earnings through increased spending among high-net-worth clients. Amid market volatility, AmEx's positioning in consumer finance offers upside potential as economic indicators stabilize. Investors anticipate a rebound if consumer spending data supports premium services growth.

American Express stock retreated on March 13, 2026, prompting portfolio managers to track it closely for additional purchases amid a favorable risk-reward setup. The pullback follows premium card refreshes like Platinum, expected to boost earnings through higher spending. Managers highlight AmEx's positioning for revenue growth in a high-price consumer segment despite market volatility. A revisit to buy rating is anticipated if shares dip further.